All Stories

  1. Bullying of children with alopecia areata: let’s take action
  2. Multiple Nodules in a Newborn
  3. Predictors of perceived stress, perceived stigmatization, and body dysmorphia in patients with chronic prurigo/prurigo nodularis: Results from an observational cross-sectional multicenter European study in 17 countries
  4. Shifting the focus: Exploring happiness as a health outcome in dermatology
  5. Hudtilstanden alopecia areata, hårtap og dets innvirkning på hverdagsliv
  6. Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe
  7. A cross‐sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables
  8. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi‐centre study
  9. Classification of psychodermatological disorders: Proposal of a new international classification
  10. The next step in hyperhidrosis evaluation: Hyperhidrosis Quality of Life Index (HidroQol©) scores
  11. Risk of Developing Psychiatric Disease Among Adult Patients with Skin Disease: A 9-Year National Register Follow-Up Study in Norway
  12. White paper on psychodermatology in Europe: A position paper from the EADV Psychodermatology Task Force and the European Society for Dermatology and Psychiatry (ESDaP)
  13. Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries
  14. Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries
  15. Perceived Stress in Patients with Inflammatory and Non-Inflammatory Skin Conditions. An Observational Controlled Study Among 255 Norwegian Dermatological Outpatients
  16. Body dysmorphia in common skin diseases: results of an observational, cross‐sectional multicentre study among dermatological outpatients in 17 European countries*
  17. Exploring the EQ-5D Dimension of Pain/Discomfort in Dermatology Outpatients from a Multicentre Study in 13 European Countries
  18. Psychosocial Aspects of Adult Acne: Data from 13 European Countries
  19. Behandlingsreiser for pasienter med psoriasis
  20. ‘The psychosocial burden of alopecia areata and androgenetica’: a cross‐sectional multicentre study among dermatological out‐patients in 13 European countries
  21. Itch and Mental Health in Dermatological Patients across Europe: A Cross-Sectional Study in 13 Countries
  22. Occurrence, Chronicity and Intensity of Itch in a Clinical Consecutive Sample of Patients with Skin Diseases: A Multi-centre Study in 13 European Countries
  23. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries
  24. Psoriasis has a huge impact on teenagers
  25. Dermatologists across Europe underestimate depression and anxiety: results from 3635 dermatological consultations
  26. Wells syndrome: a case of successful treatment with omalizumab
  27. The psychosocial burden of hand eczema: Data from a European dermatological multicentre study
  28. The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study
  29. The burden of common skin diseases assessed with the EQ5D™: a European multicentre study in 13 countries
  30. Determinants of Psychosocial Health in Psoriatic Patients: A Multi­national Study
  31. Attachment Styles of Dermatological Patients in Europe: A Multi­centre Study in 13 Countries
  32. Impairment of Sexual Life in 3,485 Dermatological Outpatients From a Multicentre Study in 13 European Countries
  33. Are Common Skin Diseases among Norwegian Dermatological Outpatients Associated with Psychological Problems Compared with Controls? An Observational Study
  34. The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
  35. Definition of treatment goals for moderate to severe psoriasis: a European consensus
  36. Contact dermatitis to captopril